argenx SE retains a Hold rating due to valuation constraints and pipeline setbacks, despite strong commercial execution with VYVGART. Recent termination of TED and lupus nephritis programs narrows ...
Rezolute recently reported that its Phase 3 sunRIZE trial of ersodetug in congenital hyperinsulinism failed to meet its primary and key secondary endpoints, with hypoglycemia reductions similar to ...
The phase 2 trial showed that coramitug, an antibody targeting misfolded transthyretin in ATTR-CM, was well tolerated. A dose of 60 mg/kg resulted in a statistically significant reduction in NT-proBNP ...
Two Sarepta Therapeutics drugs for treating different genetic subsets of patients with Duchenne muscular dystrophy failed the confirmatory study required of their accelerated FDA approvals. Sarepta ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
Even though the function of single phase and three phase relays are quite similar, their applications can vary significantly. This is primarily due to the characteristics of three phase power circuits ...
Time must fly when you're having fun. Or at least when you're defending Super Earth from a huge Illuminate invasion. Helldivers 2's latest major order is the "final phase" of the battle for the divers ...
Bessent says US will weigh China's failure on 'phase one' trade deal from first term in negotiations
Treasury Secretary Scott Bessent said Tuesday the Trump administration will take into account China's lack of compliance with a trade deal from the president's first term when it finalizes a new trade ...
WATERTOWN, Mass., April 15, 2025 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (“Tectonic”), a clinical stage biotechnology company focused on the discovery and development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback